Marcia Waddington Cruz

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Hospital Universitário Clementino Fraga/CCS

Unidade:

Hospital Universitário Clementino Fraga/CCS

Departamento:

Divisão Médica DMD/HU

ORCID:

não disponível no Lattes


Formação:

  • Universidade Federal do Rio de Janeiro

    Clínica Médica | Doutorado | 1995 - 2000

  • Université Paris Diderot

    Estágio no Serviço de Neurologia Prof Said | Aperfeiçoamento | 1994 - 1994

  • Universidade Federal do Rio de Janeiro

    Clínica Médica | Mestrado | 1991 - 1994

  • Pontifícia Universidade Católica do Rio de Janeiro

    Neurologia | Especialização | 1988 - 1989

  • Sociedade Brasileira de Neurofisiologia Clínica

    Treinamento Em Eletrofisiologia Básica | Aperfeiçoamento | 1988 - 1988

  • Pontifícia Universidade Católica do Rio de Janeiro

    Neurologia | Especialização | 1987 - 1988

  • Universidade Federal do Rio de Janeiro

    Estágio no Serviço de Neurologia | Aperfeiçoamento | 1987 - 1988

  • Universidade Federal do Rio de Janeiro

    Curso Em Radiologia Básica | Aperfeiçoamento | 1985 - 1985

  • Universidade Federal do Rio de Janeiro

    Curso Em Eletrocardiografia | Aperfeiçoamento | 1985 - 1985

  • Universidade Federal do Rio de Janeiro

    Internato Médico Clínica Médica | Aperfeiçoamento | 1984 - 1984

  • Universidade Federal do Rio de Janeiro

    Estágio no Instituto de Tisiologia e Pneumologia | Aperfeiçoamento | 1984 - 1984

  • Universidade Federal do Rio de Janeiro

    Estágio Em Serviço de Emergência | Aperfeiçoamento | 1984 - 1984

  • Centre Hospitalier Regional de Clermont Ferrand

    Estágio no Serviço de Neurologia Prof M Tournillac | Aperfeiçoamento | 1983 - 1983

  • Universidade Federal do Rio de Janeiro

    Medicina | Graduação | 1979 - 1985

  • Colégio de Aplicação Fernando Rodrigues da Silveira

    | Ensino Médio (2o grau) | 1976 - 1978

  • Colégio de Aplicação Fernando Rodrigues da Silveira

    | Ensino Fundamental (1o grau) | 1967 - 1975
Laboratórios:
Nuvens de Palavras:
Artigos:

(42.76% artigos com DOI)

Titulo DOI Ano
Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS) 10.1371/journal.pone.0292435 2024
Real-life experience with inotersen at CEPARM, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro 10.1055/s-0044-1781463 2024
A multicentric study of the disease risks and first manifestations in Hereditary transthyretin amyloidosis (ATTRv): insights for an earlier diagnosis 10.1080/13506129.2023.2178891 2023
Brazilian consensus for diagnosis, management and treatment of hereditary transthyretin amyloidosis with peripheral neuropathy: second edition 10.1055/s-0043-1764412 2023
Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay 10.1080/13506129.2023.2229484 2023
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy 10.1001/jama.2023.18688 2023
Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal 10.1186/s13023-023-02910-3 2023
Hereditary transthyretin amyloid neuropathies: advances in pathophysiology, biomarkers, and treatment 10.1016/S1474-4422(23)00334-4 2023
Effect of Eplontersen on Cardiac Structure and Function in Patients With Hereditary Transthyretin Amyloidosis 10.1016/j.cardfail.2023.11.016 2023
Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey 10.1007/s40119-023-00344-3 2023
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS) 10.1186/s13023-023-02962-5 2023
Characteristics of patients with autonomic dysfunction in the Transthyretin Amyloidosis Outcomes Survey (THAOS) 10.1080/13506129.2022.2043270 2022
Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update 10.1186/s13023-022-02359-w 2022
A natural history analysis of asymptomatic gene carriers as they develop symptomatic transthyretin amyloidosis in the Transthyretin Amyloidosis Outcomes Survey (THAOS) 10.1080/13506129.2022.2070470 2022
Liver-directed drugs for t amyloidosis 10.1111/jns.12519 2022
Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen 10.1007/s40120-022-00414-z 2022
Feasibility of assessing progression of transthyretin amyloid polyneuropathy using nerve conduction studies: findings from the Transthyretin Amyloidosis Outcomes Survey ( ) 10.1111/jns.12444 2021
10.1186/s13023-021-01834-0. 10.1186/s13023-021-01834-0. 2021
Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS) 10.1007/s40120-021-00258-z 2021
Early Data on Long-term Impact of Inotersen on Quality-of-Life in Patients with Hereditary Transthyretin Amyloidosis Polyneuropathy: Open-Label Extension of NEURO-TTR 10.1007/s40120-021-00268-x 2021
Posicionamento sobre Diagnóstico e Tratamento da Amiloidose Cardíaca ? 2021 2021
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-LRx (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy 10.1007/s40120-021-00235-6 2021
Evaluation of Mortality During Long-Term Treatment with Tafamidis for Transthyretin Amyloidosis with Polyneuropathy: Clinical Trial Results up to 8.5 Years 10.1007/s40120-020-00180-w 2020
Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial 10.1111/ene.14285 2020
A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis 10.1186/s13023-020-01399-4 2020
Neuropathy symptom and change: Inotersen treatment of hereditary transthyretin amyloidosis 10.1002/mus.270 23 2020
Oculoleptomeningeal Amyloidosis Due to Transthyretin p.Y89H (Y69H) Variant 10.1093/jnen/nlaa075 2020
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 10.1016/S1474-4422(20)30368-9 2020
Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis 10.1007/s00415-019-09671-9 2020
Transthyretin deposition in the eye in the era of effective therapy for hereditary ATTRV30M amyloidosis 10.1080/13506129.2018.1554563 2019
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial 10.1016/S1474-4422(18)30392-2 2019
Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series 10.1186/s13023-019-1000-1 2019
Baseline disease characteristics in Brazilian patients enrolled in Transthyretin Amyloidosis Outcome Survey (THAOS) 10.1590/0004-282x20180156 2019
Late-onset hereditary ATTR V30M amyloidosis with polyneuropathy: Characterization of Brazilian subjects from the THAOS registry 10.1016/j.jns.2019.05.030 2019
Inflammatory profiling of patients with familial amyloid polyneuropathy 10.1186/s12883-019-1369-4 2019
Inotersen for the treatment of adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis 10.1080/17512433.2019.1635008 2019
Geographic distribution of ATTR cases from CEPARM across the Brazilian territory and their clinical aspects, demographics, ethnical and family background 10.1080/13506129.2019.1582518 2019
Albumin/creatinine (uACR) and protein/creatinine (uPCR) ratios in spot urine samples can be used to evaluate albuminuria and proteinuria in hereditary transthyretin amyloidosis patients 10.1080/13506129.2019.1582506 2019
Tafamidis for autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis: a review 10.1007/s10286-019-00625-9 2019
Estimating the global prevalence of transthyretin familial amyloid polyneuropathy 10.1002/mus.26034 2018
Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial 10.1080/13506129.2018.1503593 2018
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis 10.1056/NEJMoa1716793 2018
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy 10.1056/NEJMoa1805689 2018
Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy 10.1590/0004-282x20180094 2018
Kind and distribution of cutaneous sensation loss in hereditary transthyretin amyloidosis with polyneuropathy 10.1016/j.jns.2018.08.031 2018
Definition and diagnosis of small fiber neuropathy: consensus from the Peripheral Neuropathy Scientific Department of the Brazilian Academy of Neurology 10.1590/0004-282x20180015 2018
Efficacy of Tafamidis in Transthyretin Amyloid Cardiomyopathy in the ATTR-ACT Trial: Sensitivity Analyses Further Support the Primary Results 10.1016/j.cardfail.2018.11.008 2018
Applying an artificial neural network model for developing a severity score for patients with hereditary amyloid polyneuropathy 10.1080/13506129.2017.1343714 2017
The demographic, genetic, and clinical characteristics of Brazilian subjects enrolled in the Transthyretin Amyloidosis Outcomes Survey 10.1080/13506129.2017.1291423 2017
Epidemiological and clinical characteristics of persons with transthyretin hereditary amyloid polyneuropathy: a global synthesis of 532 cases 10.1080/13506129.2017.1292902 2017
The demographic, genetic, and clinical characteristics of Latin American subjects enrolled in the Transthyretin Amyloidosis Outcomes Survey 10.1080/13506129.2017.1292239 2017
Global epidemiology of transthyretin hereditary amyloid polyneuropathy: a systematic review 10.1080/13506129.2017.1292903 2017
Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy 10.1080/13506129.2016.1207163 2016
Randomized Trial of Thymectomy in Myasthenia Gravis 10.1056/NEJMoa1602489 2016
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis 10.1016/j.jacc.2016.03.596 2016
Liver Transplantation for Hereditary Transthyretin Amyloidosis 10.1097/TP.0000000000000574 2015
A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis 10.1007/s40120-015-0031-3 2015
Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis 10.1016/j.jacc.2015.09.075 2015
Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study 10.1186/s13023-015-0326-6 2015
Identification of a new variant of TTR involved in familial amyloid cardiomyopathy (FAC) in Brazil: from the patient to the protein 10.1186/1750-1172-10-s1-p55 2015
Early intervention with tafamidis provides long-term benefit in delaying neurological progression in patients with transthyretin familial amyloid polyneuropathy 10.1186/1750-1172-10-S1-P12 2015
The phenotypical expression of an European inherited TTR amyloidosis in Brazil 10.1186/1750-1172-10-S1-O7 2015
Long term effects of tafamidis treatment on transthyretin familial amyloid polyneuropathy (TTR-FAP): interin results from the FX1A-303 study 2014
Guideline of transthyretin-related hereditary amyloidosis for clinicians 10.1186/1750-1172-8-31 2013
Interim results from phase II Trial on ALN-TTR02, a novel RNAi Therapeutic for the treatment of Familial Amyloidotic Polyneurpathy 2013
Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy 10.1007/s00415-013-7051-7 2013
Structure-Based Analysis of A19D, a Variant of Transthyretin Involved in Familial Amyloid Cardiomyopathy 10.1371/journal.pone.0082484 2013
Tafamidis for transthyretin familial amyloid polyneuropathy 2012
Regional differences and similarities of familial amyloidotic polyneuropathy (FAP) presentation in Brazil 2012
Long-term effects of tafamidis for the treatment of transthyretin familial amyloidotic polyneuropathy 2012
Baseline demographics of brazilian patients in THAOS 2012
Motor Neuron Disease and Acquired Axonal Neuropathy Association in HIV Infection: Case Report and Update 10.2174/157016212803901329 2012
An evaluation of the quality of life in symptomatic patients in the Transthyretin Amyloidosis Outcome Survey (THAOS). 2011
Penetrance estimation of TTR familial amyloid polyneuropathy (type I) in Brazilian families 2009
Discordant expression of familial amyloid polyneuropathy in homozygotic brazilian twins 2009
A landmark clinical trial of a novel small molecule transthyretin (TTR) stabiliser, Fx-1006 A, in patients with TTR amyloid polyneuropathy: a phase II/III randomised, doulble blind, placebo-controled study 2008
Correlation of clinical outcomes and disease burden in patients with transthyretin (TTR) amyloid polyneuropathy: study Fx-005 a landmark clinical treial of Fx-1006 A, a novel small molecule TTR stabiliser 2008
On the origin of the transthyretin Val30Met familial amyloid polyneuropathy 2008
Cortical Myoclonus Masquerading as spinal myoclonus 2008
Penetrance estimation and haplotype analysis of TTR val30met mutation on Brazilian families with familial amyoidotic polyneuropathy type I 2007
Ten-year experience with liver transplantation for familial amyloidotic polyneuropathy type I in Rio de Janeiro 2007
Liver transplantation for familial amyloidotic polyneuropathy 2007
Perfil dos pacientes com miastenia gravis de um Hospital Universitário Federal do Rio de Janeiro 2006
Video-assisted thoracoscopic cervical thymecomy for myasthenia gravis a 3 year experience at Clementino Fraga Filho University Hospital 2006
Discordant Expression of Familial Amyloid Neuropathy in a pair of monozygotic brazilian twins 2006
Penetrance estimation of TTR val 30 met mutation in Brazilian families with familial amyloidotic polyneuropathy using a survical analysis approach 2006
Discordant expression of familial amyloid polyneuropathy in a pair of monozygotic brasilizan twins 2006
Difference of penetrance in transthyretin amyloid neuropathies across families from european and brazilian origin 2006
Non-paraneoplastic Lambert-Eaton myasthenic syndrome with severe gastrointestinal dysfunction. Case report 2005
Initial results of video-assistend thoracoscopic cervical thymectomy for myasthenia gravis at Clementino Fraga Filho 2004
Eletroneuromyography study before and after liver transplantation in Brazilian Familial amyloidotic polyneuropathy type I patients 2004
Clinical survey before and after liver transplantation in Brazilian Familial Amyloidotic Polyneuropathy Type I patients 2004
Polineuropatia do doente crítico no centro de terapia intensiva da Universidade Federal do Rio de Janeiro 2002
Liver transplantation for familial amyloidotic polyneuropathy, Clinical and electroneuromyography study. 2001
Neuropatia Atáxica sensitiva após raquianestesia 2000
Lesão da ponta anterior da medula e hipertiroidismo. Relato de dois casos 2000
Relato de Caso: Disautonomia idiopática 2000
Estudo eletroneuromiográfico em pacoentes críticos noc entro de terapia intensiva (CTI) do Hospital Universitário Clementino Fraga Filho 2000
Síndrome de Eaton Lambert com ausência de anticorpos anti canal de cálcio 2000
Transplante hepático em pacientes com polineuropatia amiloidótica familiar: Estudo clínico e eletroneuromiográfico 2000
Estudo clínico e eletroneuromiográfico em pacientes em tratamento com talidomida 2000
Citopatia Mitocondrial. Relato de Caso 1999
Polineuropatia Amiloidótica familiar. Estudo clínico e eletroneuromiografia pré e pós transplante hepático 1998
Acometimento cardíaco na polineuropatia amiloidótica familiar tipo I 1998
ENMG and somatosensory evoked potential study in patients in the chronic phase of Chagas disease 1997
Levantamento da casuística do setor de neurofisologia clínica do serviço de neurologia do HUCFF / UFRJ 1996
Miastenia Gravis. Experiência clínica e cirúrgica do HUCFF-UFRJ 1996
Painful legs and moving toes 1996
Polineuropatia amilodótica familiar tipo I. estudo clínico e eletroneuromiográfico pré e pós transplante hepático 1996
Electroneuryography and neuromuscular findings in 16 primary hypothyroidsm patients 1996
Liver transplantation in FAP type I Brazilian patients 1996
Estudo clínico e eletrofisiológico em pacientes com a forma crônica da doença de Chagas 1995
Inervação anômala da musculatura intrínseca da mão pouso usual, associada à Síndrome do Túnel do Carpo Bilateral 1995
Eletroneuromiografia. Atuação no diagnóstico das doenças neuromusculares 1995
Electroneuromyography in primary hypothyroidism 1995
Electroneuromyography and somatosensory evoked potentials in tropical spastic paraparesis patients 1995
Manifestações neuromusculares no hipotiroidismo primário. Revisão bibliográfica 1994
Manifestações neuromusculares no hipotiroidismo primário 1994
Eletromiografia em pacientes com hipotiroidismo primário 1994
Eletromiografia e potenciaisevocados somatosensitivos em pacientes com mielopatia associada ao HTLV-I 1994
Miasthenia Gravis and vitiligo 1994
Myelopathy and HTLV-I ENMG and SSEP study 1993
ENMG study in primary hypothyroidism 1993
Self mutilation in neuropsychiatric disorders 1993
Calcinose associada a quadro neuromiopático. Relato de caso 1992
Mielopatia associada à infecção por HTLV-I 1992
Perfil das EMG realizadas no laboratório de neurofisiologia clínica do HUCFF-UFRJ 1992
Neuro Behcet e Siringomielia1 1992
Múltiplas compreenssões de nervo periférico de causa indeterminada. Relato de caso 1992
Lesão de nervo mediano na fossa ante-cubital por punção arterial 1992
Estudo ENMG em pacientes com hipotiroidismo primário 1992
Neurotização do plexo braquial nas avulsões traumáticas 1992
Alterações eletroneuromiográficaas associadas à infecção pelo HTLV-I numa família brasileira. 1991
Estudo eletroneuromiográfico em 10 pacientes com mielopatia associada ao HTLV-I 1991
Distribuição geográfica em 35 famílias acometidas pela PAF tipo I 1990
Análise retrospectiva de 35 pacientes timectomizados por miastenia gravis 1990
Análise dos aspectos clínicos de 50 pacientes aocmpanhados por miastenia gravis 1990
Análise dos aspectos clínicos em 161 pacientes com PAF tipo I 1990
Automutilação no curso da Doença de Pick 1990
Polineuropatia amiloidótica familial do tipo português (tipo I) no Rio de Janeiro - Brasil.Um estudo sobre a origem e a distribuição geográfica de 22 famílias. 1990
Polineuropatia amiloidótica familiar tipo português. Rio de Janeiro, Aspectos clínicos em 127 pacientes de 22 famílias 1990
Epilepsia generalizada em casp de hipoparatireoidismo pós-cirúrgico 1990
Síndrome de One-and a half. A propósito de uma caso 1990
Protocolo multidisciplinar de atendimento aos pacientes com PAF tipo I 1990
Relato de duas familias negras acometidas pela PAF tipo I 1990
Familial amyloidotic poklyneuropathy of the portuguese type in Rio de Janeiro, Brazil origin and geographic distribution of 22 familes 1990
FAP type in Rio de Janeiro, Brasil. Clnical features in 127 patients from 22 familes 1990
Relato de caso com instalação rápida. Sídrome de Kearns-Sayre 1989
Encefalopatia subaguda causada pelo vírus HIV. Aspectos clínicos e laboratoriais 1989
Encefalopatia subauda causada pelo vírus HIV - Aspectos etiopatogênicos e terapêuticos 1989
Síndrome de Kearns-Sayre. Relato de caso com instalçao rápida e documentação anatomopatológica 1988
Síndrome de Lowe. Relato de caso e revisão de literatura 1988
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
Development of Guidelines on Defining and Monitoring Progression of ATTRv Amyloidosis Using the Delphi Technique 2023
Eplontersen in Hereditary ATTR-polyneuropathy: Week 66 Final Analysis of the Phase 3 NEURO-TTRansform Study 2023
Open-label extension study of patisiran, an investigational siRNA agent for familial amyloid polyneuropathy 2015
Evaluation of modifications of NIS+ 7 score in oligonucleotide trials in TTR FAP 2015
Early intervention with tafamidis provides long-term benefit in delaying neurological progression in patients with transthyretin familial amyloid polyneuropathy 2015
Analysis of transthyretin familial amyloid polyneuropathy disease progression in symptomatic V30M patients treated with tafamidis or liver tarnsplantation compared to untreated patients: an analysis from the transthyretin amyloidosis outcomes survey (THAOS) registry 2015
Identification of a new variant of TTR involved in familial amyloid cardiomyopathy (FAC) in Brazil:from the patient to the protein 2015
Early intervention with tafamidis provides long-term benefit in delaying neurological progression in patients with transthyretin familial amyloid polyneuropathy 2015
The phenotypical expression of an European inherithed TTR amyloidosis in Brazil. 2015
Bseline demographics of Brazilian Patients in THAOS 2012
The transthyretin amyloidosis outcomes survey 2012
Long-term effects of tafamidis for the treatment of transthyretin familial amyloidotic polyneuropathy 2012
Description of neuropathic symptoms reported by ATTR patients in THAOS: the Transthyretin Amyloidosis Outcomes Survey 2012
Nerve conduction, neurologic assessment, and quality of life in symptomatic patients enrolled in THAOS: the Transthyretin Amyloidosis Outcomes Survey 2012
Follow-up of transthyretin amyloidosis patients with liver transplants or receiving tafamidis treatment as documented in THAOS: the Transthyretin Amyloidosis Outcomes Survey 2012
Demographics and Neurologic Function in Early-and Late ? Onset Symptomatic Patients in the Transthyretin Amyloidosis Outcomes Survey (THAOS). 2011
Early-Treatment Effects of Tafamiddis in Transthyretin Type Familial Amyloid Polyneuropathy. 2011
Tafamidis and nerve fiber function in transthyretin-type familial amyloid polyneuropathy 2011
Nerve Conduction in symptomatic patients in the transthyretin amyloidosis outcomes survey 2011
Baseline nutritional status in symptomatic patients in the Transthyretin Amyloidosis Outcomes Survey (THAOS). 2011
ATTR transplantation consensus pannel 2009 2010
Tafamidis (FX-1006 A): a first-in-class disease- modifying therapy for transthyretin familial amyloid 2010
Sustainability of response to tafamidis, a diseasemodifying therapy for transthyretin type familial amyloid polyneuropathy 2010
Initial findings from the transthyretin amyloidosis outcomes survey (THAOS) - A Global Web-based Registry 2010
A landmark clinical trial of a novel small molecule transthyretin (TTR) stabiliser Fx-1006 A, in patients with TTR amyloid polyneuropathy: a phase II/III, randomised, doulble blind, placebo-controled study 2009
A landmark clinical trial of a novel small molecule transthyretin (TTR) stabiliser Fx-1006 A, in patients with TTR amyloid polyneuropathy: a phase II/III, randomised, doulble blind, placebo-controled study 2008
Correlation of clinical outcomes and disease burden in patients with transthyretin (TTR) amyloid polyneuropathy: study FX-005 a landmark clinical trial of Fx-1006 A, a novel small molecule TTR stabiliser 2008
Penetrance estimation and haplotype analysis of TTR val 30 met mutation of Brazilian families with familial amyloidotic polyneuropathy type I 2007
Ten-year experience with liver transplantation for familial amyloidotic polyneuropathy type I in Rio de Janeiro/Brazil 2007
Liver transplantation for familial amyloidotic polyneuropathy 2007
Penetrance estimation of TTR val30met mutation in Brazilian families with familial amyloidotic polyneuropathy using a survival analysis approach 2006
Discordant expression of familial amyloid neuropathy in a pair of monozygotic brazilian twis 2006
Assisted thiraciscopic cervical thymectomy for myasthenia gravis a 3 years experience at Clementino Fraga Filho University Hospital 2006
Perfil dos pacientes com miastenia gravis de um hospital universitário federal do rio de janeiro 2006
Discordant expression of familial amyloid polyneuropathy in a pair of monozygotic Brasilian twins 2006
Difference of penetrance in transthyretin amyloid neuropathies across families from european and brazilian origin 2006
Non-paraneoplastic Lambert-Eaton myasthenic syndrome with severe gastrointestinal dysfunction. Case report 2005
Initial results of video-assisted thoracoscopia cervical thymectomy for myasthenia gravis at Clementino Fraga Filho University Hospital 2004
Electroneuromyography study before and after liver transplantation in Brazilian familial amyloidotic polyneuropathy type I patients 2004
Polineuropatia do doente crítico no centro de terapia intensiva da UFRJ 2002
Liver transplantation for familial amyloidotic polyneuropathy. Clinical and eletroneuromyography study 2001
Liver transplantation for familial amyloidotic polyneuropathy. Clinical and electroneromyography study 2001
Estudo clínico e eletroneuromiográfico em pacientes em tratamento com talidomida 2000
Transplante hepático em pacientes em polineuropatias amiloidótica familiar. Estudo clínico e eletroneuromiográfico 2000
Síndrome de Eaton Lambert com ausência de anticorpos anti canal de cálcio 2000
Estudo eletroneuromiográfico em pacientes críticos noc entro de terapia intensiva do HUCFF 2000
Disautonomia idiopática 2000
Lesão da ponta anterior da medula e hipertiroidismo. Relato de dois casos 2000
Neuropatia atáxica sensitiva após raquianestesia 2000
Miosite por corpos de inclusão 1999
Miosite eosinofílica. Relato de caso 1999
Citopatia mitocondrial. Relato de caso 1999
Avaliação evolutiva de pacientes com polineuropatia amiloidótica familiar submetidos a transplante de fígado 1999
Polineuropatia amiloidótica familiar PAF. Estudo clínico e eletroneuromiográfia pré e pós transplante hepático 1998
Acometimento cardíaco ne polineuropatia amiloidpotica familiar tipo I 1998
Electroneuromyography and somatosensory evoked potentials in HTLV-I associated myelopathy 1998
Familial amyloidotic polyneuropathy. Clinical profile and elestroneuromyography before and after liver transplantion 1998
Electrneuromyography (ENMG) and somatosensory evoked potentials (EP) in HTLV-I associated myelopathy 1998
Familial amyloidotic polyneuropathy (FAP) clinical profile and electroneuromyography before and after liver transplantation 1998
PAF - tipo I. Estudo clínico e eletroneuromiográfico pré e pós transplante hepático 1997
ENMG e PESS na mielopatia pelo HTLV -I 1997
Avaliação clínica e por ENMG antes e pós transplante hepático em apcientes com PAF tipo I 1997
Polineuropatia amiloidótica. relato de caso 1996
Polineuropatia amiloidótica familiar tipo I PAF. Estuido clínico e eletroneuromiográfico (ENMG) pré e pós transplante hepático 1996
Miastenia Gravis. Experiência clínica e cirúrgica do HUCFF-UFRJ 1996
Painful legs and moving toes 1996
Inervação anômala da musculatura da mão pouco usual associada à Síndrome do Túnel de carpo bilateral 1995
Estudo clínico e eletrofisiológico em pacientes com a forma crônica da Doença de Chagas (DC) 1995
Electroneuromyography and somatosensory evoked potentials in tropical spastic paraparesis patients. 1995
Liver transplantation in FAP type I brazilian patients 1995
Eletroneuromyography and somatosensory evoked potentials in tropical spastic paraparesis patients 1995
Manifestações neuromusculares do hipotireoidismo primário 1994
Eletroneuromiografia em pacientes com hipoteoirdismo primário 1993
Eletroneuromiografia e potenciais evocados somatosensitivos em pacientes com mielopatia associado ao HTLV-I 1993
Myelopathy and HTLV-I. ENMG and SSEP study 1993
ENMG study in primary hypothyroidism 1993
Myelopathy and HTLV-I 1993
ENMG and SSEP study 1993
Mielopatoa assoaciada à infecção por HTLV-I 1992
Perfil das EMG realizados no laboratório de neurofisiologia clínica de HUCFF-UFRJ 1992
Neuro Behcet e Siringomieila 1992
Múltiplas compressões de nervos periféricos de causa indeterminada. Relato de caso 1992
Lesão do nervo mediano na fossa ante-cubital por punção arterial 1992
Estudo ENMG em pacientes com hipotireoidismo primário 1992
Cacinose associada a quadro neuromiopático. Relato de caso 1992
Estudo ENMG em paientes com hipotireoidismo primário 1992
FAP type I in black patients report on two brazilian families 1992
Neurohanseníase - Case report 1992
Familal amyloidotic polyneuropathy type I. A Case report 1992
Familial amyloidotic polyneuropathy type I - a case report 1992
Alterações eletroneuromiográficas associadas a infecção pelo HIV-I numa família brasileira 1991
Estudo eletroneuromiográfico em 10 pacientes com mielopatia associada ao HTLV-I 1991
Clinical Aspects in 191 patients from Rio de Janeiro - Brazil 1991
Neurological disorders associated with HTLV-I infection in a Brazilian family 1991
Myelopathy and HTLV-I electromyography study 1991
Familial amyloidotic polyneuropathy type I. Clinical aspects in 191 patients from Rio de Janeiro 1991
Familial amyloidotic polyneuropathy type I. Geographical distribution of 35 families 1991
Neurological disorders associated with HTLV-I infection in a Brazilian family 1991
Protocolo multidisciplinar de atendimento aos pacientes com FAP tipo I 1990
Relato de duas familias negras acometidas pelo PAF tipo I 1990
Distribuição geográfica em 35 famílias acometidas pelo PAF tipo I 1990
Análise retrospectiva de 35 pacientes timectomisados por miastenia gravis 1990
Análise dos aspectos clínicos de 50 pacientes acompanhados por miastenia gravis 1990
Análise dos aspectos clínicos em 161 pacientes com polineuropatia amiloidótica familiar tipo I - PAF tipo I 1990
Automutilação no curso da Doença de Dick 1990
Automutilação no curso da Doença de Pick 1990
Familial Amyloidotic Polyneuropathy of the portuguese type in RJ - Brazil. A study of the origin on geografic distribution in 22 families 1989
Familial amyloidotic polyneuropathy of the portuguese type in Rj-Brasil. Clinical features in 127 patientes from 22 familes 1989
Síndrome de Kearns-Sayer. Relato de caso com instalação rápida e ocumentação anatomopatológica 1988
Síndrome de Lowe. Relato de caso e revisão da literatura 1988
Publicações:
Minha Rede: